Thursday, August 1, 2019

Zydus completes phase III trials of Diabetes drug in India: Company

Zydus completes phase III trials of Diabetes drug in India: Company "The trial was a multi-centric, randomised, double blind study to evaluate the safety and efficacy of 2mg and 4mg of Saroglitazar compared to Pioglitazone 45mg in patients with type 2 Diabetes Mellitus.

from Moneycontrol Business News https://ift.tt/2Kxa80H
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...